User Reviews for Motrin

Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new...

Subcutaneous Administration of Conditionally Active Recombinant Human Cathepsin Was Well Tolerated   Download image SAN DIEGO, Jan. 31, 2012 /PRNewswire/...

The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and...

Kalydeco (ivacaftor) has been approved by the U.S. Food and Drug Administration to treat the root cause of a rare form of the inherited disease cystic...

More than 40 percent of rheumatoid arthritis patients live a sedentary life, a new study finds. It used to be thought that medication and rest was the best...